Preliminary results of raltitrexed in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, real-world study.

被引：0
|
作者：
Li, Jin
Qin, Shukui
Zhou, Ai-Ping
Zhang, Yanqiao
Yuan, Xianglin
Qin, Baoli
Zeng, Shan
Shen, Lin
Yuan, Ying
Zhu, Liangjun
Wang, Weibo
Zhang, Xianwen
Liang, Jun
Ye, Feng
Chen, Ping
Wang, Huaizhang
Yu, Zhengyan
Fang, Yong
Yue, Lu
Xiong, Jianping
机构：
[1] Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China
[2] Nanjing Univ Chinese Med, Jinling Hosp, Nanjing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China
[4] Harbin Med Univ, Affiliated Canc Hosp, Harbin, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China
[6] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[7] Cent South Univ, Dept Oncol, Xiangya Hosp, Changsha, Peoples R China
[8] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China
[9] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Peoples R China
[10] Jiangsu Canc Hosp, Nanjing, Peoples R China
[11] Shandong Shengli Hosp, Jinan, Peoples R China
[12] Subei Peoples Hosp, Yangzhou, Peoples R China
[13] Peking Univ, Int Hosp, Beijing, Peoples R China
[14] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[15] Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China
[16] Mudanjiang Canc Hosp, Mudanjiang, Peoples R China
[17] ZheJiang Univ, Sir Run Run Shaw Hosp, Internal Med Oncol, Sch Med, Hangzhou, Peoples R China
[18] Qingdao Univ, Med Coll, Affiliated Hosp, Dept Oncol, Qingdao, Peoples R China
[19] Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Jiangxi, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3591
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study.
    Signorelli, Carlo
    Schirripa, Marta
    Chilelli, Mario Giovanni
    Calegari, Maria Alessandra
    Basso, Michele
    Anghelone, Annunziato
    Lucchetti, Jessica
    Minelli, Alessandro
    Angotti, Lorenzo
    Gemma, Donatello
    Dell'Aquila, Emanuela
    Cosimati, Antonella
    Arrivi, Giulia
    Morelli, Cristina
    Corsi, Domenico Cristiano
    Saltarelli, Rosa
    Morandi, Maria Grazia
    Zoratto, Federica
    Santamaria, Fiorenza
    Ruggeri, Enzo Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 45 - 45
  • [22] Predictive and prognostic factors in metastatic colorectal cancer patients treated with fruquintinib: A multicenter real-world analysis
    Zhang, C.
    Wang, Y.
    Xu, J.
    Dong, M.
    Liu, K.
    Lu, Y.
    Chen, K.
    Cao, Y.
    Shi, H.
    Bei, Y.
    Li, J.
    Zhao, J.
    Cao, Y.
    Lu, N.
    Liu, H.
    Cai, P.
    Li, K.
    Yang, T.
    He, N.
    Dong, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S44 - S44
  • [23] Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study.
    Yang, Kaili
    Han, Lu
    Zhao, Yun-Bo
    Ge, Yang
    Li, Qin
    Wang, Yusheng
    Wu, Shikai
    Zhang, Yan
    Zhao, Chuanhua
    Zhou, Jing
    Zhao, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Fruquintinib in refractory metastatic colorectal cancer: a multicenter real-world study ( vol 9, 103702, 2024)
    Xu, D.
    Zeng, S.
    Qiu, W.
    Wang, G.
    Qin, Z.
    Liu, Y.
    Zhou, S.
    Zhang, Z.
    Chang, W.
    Feng, Q.
    Xu, J.
    ESMO OPEN, 2025, 10 (02)
  • [25] Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study
    Garcia-Alfonso, P.
    Garcia-Gonzalez, G.
    Gallego, I
    Peligros, M., I
    Ortega, L.
    Torres Perez-Solero, G.
    Sandoval, C.
    Munoz Martin, A.
    Blanco Codesido, M.
    Calvo Ferrandiz, A.
    Martin, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (01): : 122 - 129
  • [26] Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study
    P. García-Alfonso
    G. García-González
    I. Gallego
    M. I. Peligros
    L. Ortega
    G. Torres Pérez-Solero
    C. Sandoval
    A. Muñoz Martin
    M. Blanco Codesido
    A. Calvo Ferrándiz
    M. Martin
    Clinical and Translational Oncology, 2021, 23 : 122 - 129
  • [27] Does nutritional status affect treatment tolerability and efficacy in metastatic colorectal cancer (mCRC) patients? Results of a prospective multicenter study.
    Barret, M.
    Malka, D.
    Aparicio, T.
    Bonnetain, F.
    Dalban, C.
    Locher, C.
    Sabate, J.
    Louafi, S.
    Mansourbakht, T.
    Attar, A.
    Taieb, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study
    Zheng, Hong
    Gao, Yunong
    Guo, Hongyan
    Li Li
    Li, Qingshui
    Cui, Heng
    Lin, An
    Sun, Lixin
    Hu, Yuanjing
    Kang, Shan
    Duan, Wei
    Pan, Lingya
    Wang, Shuzhen
    Yang, Yingjie
    Li, Yunxia
    Kong, Weimin
    Xiang, Yang
    Tian, Xiaofei
    Ling, Bin
    Ha, Chunfang
    Bai, Wenpei
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1735 - 1742
  • [29] A prospective multicenter observational study of bevacizumab for the treatment of metastatic colorectal cancer in Chinese patients (Obtain study).
    Wang, Fenghua
    Dai, Guanghai
    Deng, Yanhong
    Tang, Yong
    Wang, Wei
    Niu, Zuoxing
    Bi, Feng
    Zhu, Liangjun
    Guo, Zengqing
    Yan, Jin
    Hu, Bing
    Tao, Min
    Yang, Shujun
    Zhang, Suzhan
    Wen, Lu
    Xu, Ruihua
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"
    Coutzac, Clelia
    Trouilloud, Isabelle
    Pascal, Artru
    Henriques, Julie
    Masson, Therese
    Doat, Solene
    Bouche, Olivier
    Coriat, Romain
    Saint, Angelique
    Moulin, Valerie
    Vernerey, Dewi
    Gallois, Claire
    De La Fouchardiere, Christelle
    Tougeron, David
    Taieb, Julien
    CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 132 - 140
12345